Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
895.5 INR | +2.14% | +0.34% | +38.06% |
Apr. 09 | Strides Pharma Science Gets US FDA Nod for Fluoxetine Tabs | MT |
Jan. 30 | Transcript : Strides Pharma Science Limited, Q3 2024 Earnings Call, Jan 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+38.06% | 966M | |
+20.18% | 43.75B | |
+27.47% | 22.06B | |
+14.63% | 14.46B | |
+13.35% | 13.62B | |
+39.36% | 11.61B | |
-9.54% | 6.9B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+9.64% | 5.32B |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Strides Pharma Science Arm Gets US FDA Nod for Icosapent Ethyl Capsules